CloudCheckr unveils a new Business Partner Program at AWS re
Category: #tech  By Nikita Chaurasia  Date: 2019-12-03
  • share
  • Twitter
  • Facebook
  • LinkedIn

CloudCheckr unveils a new Business Partner Program at AWS re

CloudCheckr, a renowned New York based cloud management solution company, has reportedly revealed a world-class partner enablement program at the AWS (Amazon Web Services) re. The new program enables IaaS and cloud service sellers to build a profitable cloud practice on hybrid cloud management.

The new program delivers sales enablement tools, business expertise, and cloud technology that resellers and management service providers (MSPs) require to grow their cloud services practice. The CloudCheckr CMP (cloud management platform) enables resellers registered in the program to receive access to a committed team aligned to their business development requirements.

Elissa Livingston, Vice President, Strategic Alliances and Partner Programs at CloudCheckr, reportedly stated that their partners have used CloudCheckr to create profit margin, to deliver well-managed, secure environments and to engage the customers. Livingston further stated that the company is enhancing its commitment to a worldwide business partner enablement with a partner-centric approach that provides resources, tools and support that the business partners need to win in this competitive space.

Matt Jordan, Vice President, JHC Technology, expressed his views stating that the partnership has been a driving force to provide customers an in-depth insight into security, speed and to manage their cloud environments. The company being a part of the new business partner program is looking forward to aligning with the CloudCheckr team with active support for themselves and their customers along with the marketing initiatives available during the start of the new program.

Upholding the world-class channel enablement are program improvements that include opportunities to participate in joint webinars, live events and marketing campaigns, co-branding and white label options that improve the partners brand. Also encompassed are different cloud service offerings that are powered by cloud management platforms that manage, govern and secure the most susceptible environment in the world, a market strategy to generate profits, marketing campaign to strengthen persona based and vertical segmentation with focus on customer targeting and committed relationships leading to more revenues and to build greater trust for customers and prospects.
 

Source credit: https://www.prnewswire.com/news-releases/cloudcheckr-announces-strategic-business-partner-program-300966886.html

  • share
  • Twitter
  • Facebook
  • LinkedIn


About Author

Nikita Chaurasia    

Nikita Chaurasia

Having always been daft at wordplay, Nikita Chaurasia, post the completion of post-graduation, commenced her journey into the content generation cosmos. Endowed with a professional MBA degree in Advertising and Public Relations, Nikita strives to integrate her creativ...

Read More

More News By Nikita Chaurasia

Tmunity doses first patient in Phase 1 CART-TnMUC1 clinical trial
Tmunity doses first patient in Phase 1 CART-TnMUC1 clinical trial
By Nikita Chaurasia

Tmunity Therapeutics Inc., a clinical-stage biotherapeutics firm focused on advanced T-cell immunotherapy, has reportedly dosed the first patient in its Phase 1 CART-TnMUC1-01 clinical trial with TnMUC1 (Tn/STn glycoform of mucin 1) CAR-T (chimeric a...

Hyundai and Uber team up to develop all-electric flying taxis
Hyundai and Uber team up to develop all-electric flying taxis
By Nikita Chaurasia

In the midst of technological advancements increasing at a commendable pace, Uber’s flying taxi initiative seems to be edging closer to reality – the reality of establishing flying cars in the near future. The ride-hailing giant has appar...

BioXcel begins Phase 3 BXCL501 trial for treating SCZ & bipolar disorder
BioXcel begins Phase 3 BXCL501 trial for treating SCZ & bipolar disorder
By Nikita Chaurasia

BioXcel Therapeutics, Inc., a clinical-stage biopharmaceutical firm leveraging artificial intelligence approaches to advance the next wave of medicines in immuno-oncology and neuroscience, has reportedly announced the initiation of its SERENITY progr...